A fast and easy way to find out about all new FDA approved cancer treatments.
Friday, January 10, 2014
New combination for melanoma
The FDA has approved the combination of trametinib (Mekinist) and dabrafenib (Tafinlar) for the treatment of unresectable malignant melanoma and metastatic melanoma with BRAF V600E or V600K mutations.
No comments:
Post a Comment